Русский
Nederlandse taal
Deutsch
Francés
한국어
Português
Español
日本語
ไทย
Hyaluron Mesotherapie
Ingredient: 16mg/ml HA,18 types of amino acids, Polypeptide, Vitamin, Antioxidant, Mineral substances.
Specification: 3ml,5ml
Package: Bottle
Application Area: Moisturize, anti-aging, add a variety of nutrients to the skin, lighten the skin tone.
Product Introduction：
Hyaluronic Acid's biocompatibility ensures that it integrates well with the body’s tissues, making it a preferred material for medical applications such as dermal fillers and joint injections. This advanced hydration complex deeply nourishes, brightens, and repairs skin while slowing the aging process, stimulating collagen renewal, and enhancing the skin’s antioxidant defense system.
Product Display：
Product Details:
Type | MESO18AA+ |
Specification | 3ml, 5ml |
Application area | Facial dermal mesoderm |
Product efficacy | Moisturize, anti-aging, add a variety of nutrients to the skin, lighten the skin tone |
How to choose | According to the customer's skin type, age and customer needs to choose |
Package | Bottle |
Storage | Room temperature (1-25ºC), cool and dry place |
Recommended | 1-2 pc |
Recommended interval | 2-3 months |
Lasting time | 2-3 months |
Heavy metal residue | ≤10μg/g |
Endotoxin content | <0.5EU/mL |
Product Package:
Customer Feedback：
Raw Material Advantages：
1. Cross-linked Hyaluronic Acid in aesthetic medicine provides longer-lasting volume enhancement compared to non-cross-linked formulations, making it a preferred choice for facial contouring and wrinkle correction.
2. Hyaluronic Acid can help to reduce redness and inflammation in post-procedure treatments, accelerating recovery after laser treatments, microneedling, and chemical peels.
3. he ability of Hyaluronic Acid to create a flexible gel matrix makes it a suitable ingredient for bioengineered tissues, supporting cell growth and wound healing.
Development Process:
Company Introduction:
The R&D platform includes a highly skilled 30-member research team, a 1,426m² sub-platform in Shandong for major drug creation, a 10,000-class clean pilot workshop, microbiology and sterility laboratories, physicochemical testing capabilities, and purified water facilities, creating an ideal environment for Class III medical device research and approval. The medical material industrialization platform encompasses advanced sterile dispersion techniques for heterogeneous high-viscosity polymer implants, innovative suspension stabilization methods, research-driven gel granulation technology, and specialized packaging solutions with aseptic processing for bioactive materials.
